The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer…
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that…
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide…
The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour…
Taxol is a widely used chemotherapy drug – it has been used to treat millions…
This review is collaboratively prepared by Prof. Yingli Zhang (Hangzhou Institute of Medicine (HIM), Chinese…
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of…
Blood cancer patients in the US who may have previously struggled to find a donor…
For the first time, researchers have found that lung cancer patients who have a combination…
On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix with lenalidomide and rituximab…